Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines
Educational Objectives:
Faculty:
James Lewis, PharmD, FIDSA
ID Clinical Pharmacy Supervisor
Oregon Health & Sciences University
Portland, Oregon
James Lewis, PharmD, FIDSA, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022.
This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative
1:00:11

Pharmacists Answering the call | Pharmacy Podcast Nation
56:55

Ja'Miera Stuart PharmD | Brighter Horizons
19:30